Role of PGE2 in Human Mast Cell Biology
Role of PGE2 in Human Mast Cell Biology
批准号:
7312456
负责人:
Joshua A Boyce
金额:
$51.8万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2010-05-31
关键词:
asthmacell biologycell surface receptorsconfocal scanning microscopygene induction /repressionhormone biosynthesishuman tissueimmune responseimmunoregulationinflammationlaboratory mouseleukocyte activation /transformationmast cellposttranslational modificationsprostaglandin Eprostaglandin endoperoxide synthaserespiratory hypersensitivitysmall interfering RNAtissue /cell culture
中文摘要
肥大细胞(MC)启动过敏反应,参与抵抗感染的先天保护。通过高亲和力的Fc IgE受体(FcsRI)激活MC,诱导两种主要的二十烷类化合物的从头合成:由5-脂氧合酶/白三烯C4合成酶(5-LO/LTC4S)途径形成的半胱氨酰白三烯(CysLTS)和前列腺素(PG)D2,即PGH合成酶(PGHS)/PGD合成酶途径的产物。在体内,CysLTs和PGD2都通过特定的受体系统发挥作用,介导MC依赖的支气管收缩、白细胞募集和呼吸道高反应性。另一种二十烷类化合物PGE21对过敏性哮喘和阿司匹林耐受哮喘(AIA)都有明显的支气管保护作用。目前的初步数据显示,脐带血来源的人单核细胞(HMCs)对Toll样受体(TLR)2的配体葡萄球菌多肽(PGN)和TLR3的配体PolyI:C的刺激有反应,并延迟、持续地分泌PGE2。PGN诱导PGHS-2和微粒体PGE2合成酶-1(M-PGES-1)的mRNA及其相应蛋白的表达。值得注意的是,外源PGE2显著抑制HMCS产生cysLT和PGD2,并显著
抑制肿瘤坏死因子(TNF-a)和IL-5的产生
用PGN进行交联化或刺激。我们假设:1.先天性和获得性免疫反应引起MC产生二十烷类化合物的不同特征,其中PGHS-2和M-PGES-1均可诱导;2.PGE-通过一个以上的EP受体,以自分泌或旁分泌的方式限制MC激活的后果;以及3.AIA涉及可诱导的PGE2合成酶功能的失调。因此,我们提出了以下具体目标:1)确定通过不同跨膜刺激激活的HMCs持续合成PGE2的末端合成酶;2)确定PGE2介导的抑制HMC激活的受体和生化机制;3)确定AIA是否存在可诱导的PGE2合成系统缺陷。
英文摘要
Mast cells (MCs) initiate allergic responses and are involved in innate protection from infections. MC activation through the high-affinity Fc receptor for IgE (FcsRI) induces de novo synthesis of two major eicosanoids: cysteinyl leukotrienes (cysLTs), formed by the 5-lipoxygenase/leukotriene C4 synthase {5-LO/LTC4S) pathway, and prostaglandin (PG) D2, a product of the PGH synthase (PGHS)/PGD synthase pathway sequence. Both cysLTs and PGD2 act through specific receptor systems to mediate MC-dependent bronchconstriction, leukocyte recruitment, and airway hyperresponsiveness in vivo. Another eicosanoid, PGE2l is markedly bronchoprotective in both allergic and aspirin-intolerant asthma (AIA). Preliminary data now reveal that cord blood-derived human MCs (hMCs) respond to stimulation with staphylococcal peptidoglyan (PGN), a ligand for toll-like receptor (TLR) 2, and to poly I:C, a ligand for TLR3, with delayed, sustained secretion of PGE2. PGN induces expression of mRNAfor both PGHS-2 and microsomal PGE2 synthase-1 (M-PGES-1), along with the corresponding proteins. Notably, exogenous PGE2 markedly inhibits cysLT and PGD2 generation by hMCs, and substantially
inhibits the production of tumor necrosis factor (TNF-a) and IL-5 in response to either FcsRI
crosslinkage or stimulation with PGN. We hypothesize that 1. Innate and adaptive immune responses elicit contrasting profiles of eicosanoid generation from MCs, with PGHS-2 and M-PGES-1 being inducible in each; 2. PGE& through more than one EP receptor, limits consequences of MC activation in an autocrine orparacrine manner; and 3. AIA involves dysregulation of inducible PGE2 synthase function. We therefore propose the following Specific Aims: 1) to define the terminal synthases responsible for the sustained phase of PGE2 synthesis in hMCs activated through different transmembrane stimuli, 2) to define the receptors and biochemical mechanisms responsible for PGE2-mediated inhibition of hMC activation, and 3) to determine whether defects in the inducible PGE2 synthesis system underlie AIA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10468771
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10296403
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Control of Pulmonary Inflammation by Leukotriene E4
-
批准号:10666460
-
项目类别:
-
资助金额:$70.07万
-
财政年份:2021
-
负责人:Joshua A Boyce
-
依托单位:
Influence of NSAIDs and AERD on the expression and function of ACE2 - implications for SARS-CoV2 severity
-
批准号:10197400
-
项目类别:
-
资助金额:$11.42万
-
财政年份:2020
-
负责人:Joshua A Boyce
-
依托单位:
CysLT and P2Y Receptors in Lung Inflammation
-
批准号:10321255
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2018
-
负责人:Joshua A Boyce
-
依托单位:
CysLT and P2Y Receptors in Lung Inflammation
-
批准号:10083690
-
项目类别:
-
资助金额:$53.55万
-
财政年份:2018
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10296672
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10062848
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Hypersensitivity
-
批准号:10517922
-
项目类别:
-
资助金额:$65.65万
-
财政年份:2017
-
负责人:Joshua A Boyce
-
依托单位:
Characterization of a Novel Growth and Survival Factor for Human Mast Cells
-
批准号:8977481
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2014
-
负责人:Joshua A Boyce
-
依托单位:
Mechanisms and Consequences of Defective E Prostanoid Receptor Signaling in AERD
-
批准号:8915315
-
项目类别:
-
资助金额:$14.81万
-
财政年份:2014
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:9061003
-
项目类别:
-
资助金额:$38.43万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:8476459
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Eicosanoid Networks in Aspirin Exacerbated Respiratory Disease
-
批准号:8675938
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2013
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10456240
-
项目类别:
-
资助金额:$153.56万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology
-
批准号:10456243
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
-
批准号:9294916
-
项目类别:
-
资助金额:$197.9万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms in Aspirin Exacerbated Respiratory Disease
-
批准号:9973135
-
项目类别:
-
资助金额:$154.34万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10626842
-
项目类别:
-
资助金额:$153.56万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease
-
批准号:10260780
-
项目类别:
-
资助金额:$153.51万
-
财政年份:2011
-
负责人:Joshua A Boyce
-
依托单位:
海外基金